Indications and uses
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: sneezing runny nose itchy, watery eyes itching of the nose or throat
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: sneezing runny nose itchy, watery eyes itching of the nose or throat
may be taken with or without water chew or crush tablets completely before swallowing For 5 mg: adults and children 6 years and over 1 tablet (5 mg) or 2 tablets (10 mg) once daily depending upon severity of symptoms; do not take more than 2 tablets (10mg) in 24 hours. adults 65 years and over 1 tablet (5 mg) once daily; do not take more than 1 tablet (5 mg) in 24 hours. children under 6 years of age ask a doctor ...
store between 20° to 25°C (68° to 77°F) do not use if inner safety seal is open or torn see top layer for lot number and expiration date
For 5 mg:Cetirizine hydrochloride, USP 5 mg
For 10 mg:Cetirizine hydrochloride, USP 10 mg
Antihistamine
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.
liver or kidney disease. Your doctor should determine if you need a different dose.
you are taking tranquilizers or sedatives.
an allergic reaction to this product occurs. Seek medical help right away.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
For 5 mg:
adults and children 6 years and over | 1 tablet (5 mg) or 2 tablets (10 mg) once daily depending upon severity of symptoms; do not take more than 2 tablets (10mg) in 24 hours. |
| adults 65 years and over | 1 tablet (5 mg) once daily; do not take more than 1 tablet (5 mg) in 24 hours. |
| children under 6 years of age | ask a doctor |
| consumers with liver or kidney disease | ask a doctor |
For 10 mg:
| adults and children 6 years and over | Chew and swallow 1 tablet (10 mg) once daily; do not take more than 1 tablet (10 mg) in 24 hours. A 5 mg product may be appropriate for less severe symptoms. |
| adults 65 years and over | ask a doctor |
| children under 6 years of age | ask a doctor |
| consumers with liver or kidney disease | ask a doctor |
acesulfame potassium, colloidal silicon dioxide, compressible sugar, crospovidone, FD & C Blue No # 2 Aluminum Lake, FD & C Red No # 40 Aluminum Lake, guar gum, magnesium oxide light powder, magnesium stearate, mannitol, microcrystalline cellulose, pregelatinized starch, prosweet N & A flavor powder, talc, tutti frutti flavor
Call toll free 1-800-818-4555 weekdays
For 5 mg Allergy:
Original Prescription Strength
NDC 47335-343-83
Cetirizine Hydrochloride Chewable Tablets
5 mg
ALLERGY
Antihistamine
Indoor + Outdoor Allergies
Actual Size
Tutti-frutti Flavor
6 yrs & older
30 CHEWABLE TABLETS
SUN PHARMACEUTICAL INDUSTRIES LTD.
For 10 mg Allergy:
Original Prescription Strength
NDC 47335-344-83
Cetirizine Hydrochloride Chewable Tablets
10 mg
ALLERGY
Antihistamine
Indoor & Outdoor Allergies
Actual Size
Tutti-frutti Flavor
6 yrs & older
30 CHEWABLE TABLETS
SUN PHARMA
| Class | Version | Type | Effective |
|---|---|---|---|
| CETIRIZINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0347335344837 | GTIN-13: 0347335344837 EAN-13: 0347335344837 GTIN-12: 347335344837 UPC-A: 347335344837 GTIN storage (14 digits): 00347335344837 | spl-cetirizine-10mg-allergy-1.jpg |
| Data code | Data Matrix | 12345678910 | spl-cetirizine-10mg-allergy-1.jpg, spl-cetirizine-5mg-allergy-1.jpg |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e2db08c6-133f-4f4f-afb4-e90a2418d6f6 | Product name | 1 | 20230320 |
| c505bb17-4ff9-45f9-ac2d-bb9c8c9d35be | Product name | 1 | 20200304 |
| a255659f-db40-429d-8c07-5f173f330d9c | Product name | 1 | 20190402 |
| 11ed6f83-cdd2-4637-8379-b1a1d3ae3cde | Product name | 1 | 20181101 |
| 86c45a79-b9f0-4476-a27c-6e10db098497 | Product name | 1 | 20180125 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 47335-343-83 | Cetirizine Hydrochloride | 30 in 1 BOTTLE | TABLET, CHEWABLE | 30 | 12 | |
| 47335-343-88 | Cetirizine Hydrochloride | 100 in 1 BOTTLE | TABLET, CHEWABLE | 100 | 12 | |
| 47335-344-83 | Cetirizine Hydrochloride | 30 in 1 BOTTLE | TABLET, CHEWABLE | 30 | 12 | |
| 47335-344-88 | Cetirizine Hydrochloride | 100 in 1 BOTTLE | TABLET, CHEWABLE | 100 | 12 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 47335-343-83 | EA - Each | 47335-343 | dd3fb5df-57c2-4133-8639-9bc175692699 | 1 | 2013-02-13 |
| 47335-344-83 | EA - Each | 47335-344 | 2f6a2325-3993-475b-ac3a-8bd9cdfb34b7 | 1 | 2013-02-13 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CETIRIZINE HYDROCHLORIDE | ACTIVE INGREDIENT | 64O047KTOA | 5 | |
| CETIRIZINE | ACTIVE MOIETY | YO7261ME24 | 5 | |
| ACESULFAME POTASSIUM | INACTIVE INGREDIENT | 23OV73Q5G9 | 5 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 5 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | 5 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | 5 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | 5 | |
| GUAR GUM | INACTIVE INGREDIENT | E89I1637KE | 5 | |
| MAGNESIUM OXIDE | INACTIVE INGREDIENT | 3A3U0GI71G | 5 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 5 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | 5 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 5 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | 5 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | 5 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 5 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 47335-343 | 47335-343-83, 47335-343-88 |
| 47335-344 | 47335-344-83, 47335-344-88 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | CAPSULE, DELAYED RELEASE / ORAL | 2043 mg | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CONCENTRATE / ORAL | 0.04 mg/1ml | ||
| MANNITOL | MANNITOL | 3OWL53L36A | SOLUTION / OPHTHALMIC | 4.7 %w/v | ||
| SUCROSE | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / BUCCAL | 3 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, DELAYED RELEASE / ORAL | 144 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | GUM, CHEWING / BUCCAL | 173 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION / ORAL | 200 mg | ||
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | FILM / SUBLINGUAL | 5 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER, FOR SUSPENSION / ORAL | 120 mg | ||
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | FILM, SOLUBLE / ORAL | 10 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | TABLET / ORAL | 3391 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUPPOSITORY / RECTAL | NA | ||
| FD&C BLUE NO. 2 | FD&C BLUE NO. 2 | L06K8R7DQK | TABLET, FILM COATED / ORAL | 2 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | SUSPENSION/ DROPS / ORAL | 90 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | SUSPENSION, EXTENDED RELEASE / ORAL | 2464.6 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | CAPSULE / ORAL | 20 mg | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | SUSPENSION / ORAL | 100 mg/5ml | ||
| MANNITOL | MANNITOL | 3OWL53L36A | CAPSULE / ORAL | 1562 mg | ||
| TALC | TALC | 7SEV7J4R1U | POWDER / TOPICAL | 9235 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE / ORAL | 3568 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, SOLUTION / INTRAVENOUS | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 900 mg | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | SOLUTION / DENTAL | NA | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION, SOLUTION / INTRAVENOUS | 15400 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | TROCHE / ORAL | 14594 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / ORAL | 602 mg | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, DELAYED RELEASE / ORAL | 2 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 300 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | ELIXIR / ORAL | 18000 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | TABLET / SUBLINGUAL | 13 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, EXTENDED RELEASE / ORAL | 284.54 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| ACESULFAME POTASSIUM | ACESULFAME POTASSIUM | 23OV73Q5G9 | TABLET, FILM COATED / ORAL | 1.75 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, SUGAR COATED / ORAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 35 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, DELAYED RELEASE / ORAL | 3.2 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / NASAL | 20 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 2 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SOLUTION / ORAL | 690 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 119.12 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | SOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC | 4.35 %w/w | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | TABLET / ORAL | 63 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 47 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | CAPSULE, EXTENDED RELEASE / ORAL | 213 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION / INTRAMUSCULAR | 106.6 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, DELAYED RELEASE / ORAL | 420 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, COATED PELLETS / ORAL | 14 mg | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, COATED / ORAL | 0.1 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | SUSPENSION/ DROPS / OPHTHALMIC | 3.3 %w/v | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | SPONGE / TOPICAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | 9.4 %w/v | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| FD&C BLUE NO. 2 | FD&C BLUE NO. 2 | L06K8R7DQK | TABLET, DELAYED RELEASE / ORAL | 0.2 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, DELAYED RELEASE / ORAL | 40 mg | ||
| TALC | TALC | 7SEV7J4R1U | GRANULE, FOR SUSPENSION / ORAL | 296 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION / SUBCUTANEOUS | 675 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090142-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | CETIRIZINE HYDROCHLORIDE | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | ||
| A090142-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | CETIRIZINE HYDROCHLORIDE | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | ||
| A090142-003 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | CETIRIZINE HYDROCHLORIDE | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | ||
| A090142-004 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | CETIRIZINE HYDROCHLORIDE | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A090142-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | A090142-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | A090142-003 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | A090142-004 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | A090142-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A090142-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A090142-003 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A090142-004 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A090142-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A090142-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A090142-003 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A090142-004 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A090142-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A090142-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A090142-003 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A090142-004 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A090142-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A090142-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A090142-003 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A090142-004 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090142-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090142-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090142-003 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090142-004 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A090142-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A090142-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A090142-003 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A090142-004 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090142-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090142-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090142-003 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090142-004 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090142-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090142-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090142-003 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090142-004 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090142-001 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090142-002 | CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090142-003 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | 5MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090142-004 | CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF | 10MG | TABLET, CHEWABLE / ORAL | 2011-08-30 | 03ed91905a0d… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 568fc395-5049-7c3d-e063-6394a90a2b65 | a4758152-97dd-4a27-b4d9-11178654b93e | 2026-07-14 | Warnings | a4758152-97dd-4a27-b4d9-11178654b93e |
Adverse event summaries are temporarily unavailable. Other product information remains available.